Evidence map›Paper›PMID 38115963›Full record

ArticleThe Lancet regional health. Europe2023

Consumption of ultra-processed foods and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study.

Reynalda Cordova, Vivian Viallon, Emma Fontvieille, Laia Peruchet-Noray, Anna Jansana, Karl-Heinz Wagner, Cecilie Kyrø, Anne Tjønneland, Verena Katzke, Rashmita Bajracharya and 25 more

Open access · goldAbstract read
In one paragraph

Article in The Lancet regional health. Europe, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 143 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
143citing papers in PubMed, 8 pooled it
53.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

143 citing papers in PubMed, 8 syntheses or guidelines pooled it, 185 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

83 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 19 institutions in 12 countries.

Reynalda CordovaInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Vivian ViallonInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Emma FontvieilleInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Laia Peruchet-NorayInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Anna JansanaInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Karl-Heinz WagnerDepartment of Nutritional Sciences, University of Vienna, Vienna, Austria.
Cecilie KyrøDanish Cancer Institute Center, Copenhagen, Denmark.
Anne TjønnelandDanish Cancer Institute Center, Copenhagen, Denmark.
Verena KatzkeDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Rashmita BajracharyaDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Matthias B SchulzeDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Giovanna MasalaInstitute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
Sabina SieriEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Salvatore PanicoDepartment of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
Fulvio RicceriDepartment of Clinical and Biological Sciences, Centre for Biostatistics, Epidemiology, and Public Health, University of Turin, Italy.
Rosario TuminoHyblean Association for Epidemiological Research, AIRE ONLUS Ragusa, Italy.
Jolanda M A BoerCentre for Prevention, Lifestyle and Health, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
W M Monique VerschurenCentre for Prevention, Lifestyle and Health, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Yvonne T van der SchouwJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Paula JakszynUnit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.
Daniel Redondo-SánchezEscuela Andaluza de Salud Pública (EASP), Granada 18011, Spain.
Pilar AmianoSpanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
José María HuertaSpanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Marcela GuevaraSpanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
Yan BornéNutritional Epidemiology, Department of Clinical Sciences Malmö, The Faculty of Medicine, Lund University, Malmö, Sweden.
Emily SonestedtNutritional Epidemiology, Department of Clinical Sciences Malmö, The Faculty of Medicine, Lund University, Malmö, Sweden.
Konstantinos K TsilidisDepartment of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
Christopher MillettPublic Health Policy Evaluation Unit, School of Public Health, Imperial College London, London, United Kingdom.
Alicia K HeathDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Elom K AglagoDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Dagfinn AuneDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Marc J GunterInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Pietro FerrariInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Inge HuybrechtsInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Heinz FreislingInternational Agency for Research on Cancer (IARC-WHO), Lyon, France.
Centre international de recherche sur le cancer · FRImperial College London · GBInstituto de Salud Carlos III · ESUniversity of Vienna · ATGerman Cancer Research Center · DEMalmö University · SEUtrecht University · NLBasque Government · ESDanish Cancer Society · DKFondazione IRCCS Istituto Nazionale dei Tumori · ITInstitut Català d'Oncologia · ESItalian Association for Cancer Research · ITNational Institute for Public Health and the Environment · NLOsloMet – Oslo Metropolitan University · NOUniversity of Copenhagen · DKUniversity of Ioannina · GRUniversity of Naples Federico II · ITUniversity of Potsdam · DEUniversity of Turin · IT

Funding

Cancer Research UK 29678World Health Organization 001
6 · The paper itself

Abstract

Background: It is currently unknown whether ultra-processed foods (UPFs) consumption is associated with a higher incidence of multimorbidity. We examined the relationship of total and subgroup consumption of UPFs with the risk of multimorbidity defined as the co-occurrence of at least two chronic diseases in an individual among first cancer at any site, cardiovascular disease, and type 2 diabetes. Methods: This was a prospective cohort study including 266,666 participants (60% women) free of cancer, cardiovascular disease, and type 2 diabetes at recruitment from seven European countries in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Foods and drinks consumed over the previous 12 months were assessed at baseline by food-frequency questionnaires and classified according to their degree of processing using Nova classification. We used multistate modelling based on Cox regression to estimate cause-specific hazard ratios (HR) and their 95% confidence intervals (CI) for associations of total and subgroups of UPFs with the risk of multimorbidity of cancer and cardiometabolic diseases. Findings: After a median of 11.2 years of follow-up, 4461 participants (39% women) developed multimorbidity of cancer and cardiometabolic diseases. Higher UPF consumption (per 1 standard deviation increment, ∼260 g/day without alcoholic drinks) was associated with an increased risk of multimorbidity of cancer and cardiometabolic diseases (HR: 1.09, 95% CI: 1.05, 1.12). Among UPF subgroups, associations were most notable for animal-based products (HR: 1.09, 95% CI: 1.05, 1.12), and artificially and sugar-sweetened beverages (HR: 1.09, 95% CI: 1.06, 1.12). Other subgroups such as ultra-processed breads and cereals (HR: 0.97, 95% CI: 0.94, 1.00) or plant-based alternatives (HR: 0.97, 95% CI: 0.91, 1.02) were not associated with risk. Interpretation: Our findings suggest that higher consumption of UPFs increases the risk of cancer and cardiometabolic multimorbidity. Funding: Austrian Academy of Sciences, Fondation de France, Cancer Research UK, World Cancer Research Fund International, and the Institut National du Cancer.

Indexed as

CancerCardiovascular diseasesDiabetesDietMultimorbidityUltra-processed foods

Identifiers

PMID38115963
PMCPMC10730313
OpenAlexW4388656872

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.